aid: innovent
accessModel:
  pricing: unknown
  onboarding: unknown
  trial: false
  try_now: false
  public: false
  label: Unknown
  confidence: low
  source: []
  generated: '2026-07-22'
  method: derived
image: https://kinlane-images.s3.amazonaws.com/shared/apis-json/icons/innovent.png
name: Innovent
description: 'Innovent Biologics (信达生物制药) is a biopharmaceutical company founded in 2011 and
  headquartered in the Suzhou Industrial Park, China, that discovers, develops, manufactures, and
  commercializes high-quality biologic medicines for the treatment of oncology, autoimmune,
  cardiovascular and metabolic, and ophthalmology diseases. Its portfolio includes the PD-1 inhibitor
  Tyvyt (sintilimab), developed in partnership with Eli Lilly, alongside a broad pipeline of monoclonal
  antibodies and other biologics. Innovent is listed on the Hong Kong Stock Exchange (01801.HK) and was
  surfaced through the Hongshan (formerly Sequoia Capital China) portfolio. Innovent is a therapeutics
  company and does not publish a public developer API surface; this profile captures its corporate and
  domain-security identity in the API Evangelist network.'
url: https://raw.githubusercontent.com/api-evangelist/innovent/refs/heads/main/apis.yml
x-type: company
x-source: vc-portfolio
x-backed-by:
- hongshan
x-tier: stub
x-tier-reason: portfolio-lead
specificationVersion: '0.20'
created: '2026-07-17'
modified: '2026-07-19'
tags:
- Company
- Healthcare
- Biotechnology
- Pharmaceuticals
- Biologics
- Oncology
- Life Sciences
apis: []
maintainers:
- FN: Kin Lane
  email: kin@apievangelist.com
- FN: APIs.json
  email: info@apis.io
common:
- type: DomainSecurity
  url: security/innovent-domain-security.yml
- type: Website
  url: https://innoventbio.com
x-enrichment:
  date: '2026-07-19'
  status: backfilled
  pass: local-v1
  note: backfilled from .gitignore signal + verified work evidence